FARMACIA Y SALUD
Doktorandenschule
Hospital Universitario La Paz
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Paz (7)
2022
-
Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer
International Journal of Gynecological Cancer, Vol. 32, Núm. 8, pp. 1009-1016
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
Tofacitinib in ulcerative colitis: Real-world evidence from the ENEIDA registry
Journal of Crohn's and Colitis, Vol. 15, Núm. 1, pp. 35-42
2020
-
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease
United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066
2019
-
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500
2000
-
Potential relationship between genotype and clinical outcome in propionic acidaemia patients
European Journal of Human Genetics, Vol. 8, Núm. 3, pp. 187-194